DATOPOTAMAB DERUXTECAN

DATOPOTAMAB DERUXTECAN was reported 859 times

DATOPOTAMAB DERUXTECAN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PD-L1 PROTEIN EXPRESSION 1 0.1667
1 INFECTIOUS IRIDOCYCLITIS 1 0.1667
2 CORNEAL EPITHELIOPATHY 4 0.1053
3 MYOCARDIAL STRAIN IMAGING 1 0.0909
4 SEIZURE ANOXIC 1 0.0286
5 PROCEDURAL SHOCK 1 0.0278
6 TROPONIN 1 0.0179
7 ORAL TOXICITY 1 0.0179
8 ORAL PIGMENTATION 1 0.0139
9 CORNEAL TOXICITY 1 0.0090
10 LARYNGOPHARYNGITIS 1 0.0090
11 TUMOUR INFLAMMATION 1 0.0089
12 REFUSAL OF EXAMINATION 1 0.0076
13 ALLERGIC RESPIRATORY DISEASE 1 0.0072
14 CLOSTRIDIUM COLITIS 8 0.0066
15 KERATITIS 17 0.0056
16 MALIGNANT NEOPLASM OF SPINAL CORD 1 0.0055
17 NON-SMALL CELL LUNG CANCER STAGE IV 2 0.0055
18 OCULAR TOXICITY 6 0.0054
19 SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY 2 0.0049
20 SALIVARY GLAND PAIN 1 0.0046
21 BODY HEIGHT INCREASED 2 0.0041
22 FUNGAL PHARYNGITIS 1 0.0040
23 URINARY BLADDER RUPTURE 1 0.0039
24 CONJUNCTIVITIS VIRAL 1 0.0038
25 CORNEAL EROSION 2 0.0037
26 OCULAR SURFACE DISEASE 1 0.0036
27 OESOPHAGITIS HAEMORRHAGIC 1 0.0036
28 BREAST HAEMORRHAGE 1 0.0030
29 PNEUMONITIS CHEMICAL 1 0.0029
30 EYE SYMPTOM 1 0.0028
31 MALIGNANT ASCITES 2 0.0026
32 CARCINOEMBRYONIC ANTIGEN INCREASED 5 0.0026
33 NAIL OPERATION 1 0.0024
34 STOMATITIS 146 0.0024
35 NAIL BED DISORDER 1 0.0023
36 NEUROSIS 1 0.0022
37 DISEASE PROGRESSION 256 0.0022
38 METASTASES TO SKIN 2 0.0019
39 LYMPHANGIOSIS CARCINOMATOSA 2 0.0019
40 INFUSION RELATED HYPERSENSITIVITY REACTION 1 0.0017
41 PNEUMOMEDIASTINUM 3 0.0017
42 LARYNGEAL DISCOMFORT 1 0.0016
43 PAROTID GLAND ENLARGEMENT 1 0.0015
44 ANGULAR CHEILITIS 1 0.0014
45 PERIODONTAL DISEASE 2 0.0014
46 RESPIRATORY SYNCYTIAL VIRUS TEST POSITIVE 1 0.0014
47 CARBOHYDRATE ANTIGEN 15-3 INCREASED 1 0.0013
48 GENITAL ULCERATION 1 0.0013
49 PHARYNGEAL PARAESTHESIA 2 0.0013
50 ANAL ULCER 1 0.0012
51 SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA 1 0.0012
52 DYSCHROMATOPSIA 1 0.0012
53 MALIGNANT PLEURAL EFFUSION 2 0.0012
54 POLYNEUROPATHY 14 0.0012
55 ABDOMINAL SEPSIS 1 0.0011
56 INCORRECT PRODUCT FORMULATION ADMINISTERED 1 0.0011
57 PUNCTATE KERATITIS 1 0.0011
58 VASCULAR PAIN 1 0.0010
59 NON-SMALL CELL LUNG CANCER 5 0.0010
60 ONCOLOGIC COMPLICATION 1 0.0010
61 DUODENAL PERFORATION 1 0.0010
62 CORONAVIRUS TEST POSITIVE 1 0.0010
63 METASTASES TO PLEURA 1 0.0010
64 BLOOD SODIUM ABNORMAL 1 0.0009
65 METASTASES TO MENINGES 2 0.0009
66 PULMONARY TOXICITY 6 0.0008
67 PNEUMONITIS 23 0.0008
68 TUMOUR MARKER INCREASED 4 0.0008
69 RECTAL PROLAPSE 1 0.0008
70 PHARYNGEAL INFLAMMATION 1 0.0008
71 AMYLASE INCREASED 3 0.0008
72 XEROSIS 1 0.0008
73 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 1 0.0008
74 METASTASES TO LIVER 14 0.0008
75 INFUSION SITE IRRITATION 1 0.0008
76 METASTASES TO CENTRAL NERVOUS SYSTEM 10 0.0008
77 DACRYOSTENOSIS ACQUIRED 1 0.0008
78 RETINAL DEGENERATION 1 0.0008
79 TUMOUR PAIN 1 0.0008
80 LUNG OPACITY 2 0.0008
81 HERPES OPHTHALMIC 1 0.0008
82 PHARYNGEAL ULCERATION 1 0.0008
83 SIALOADENITIS 1 0.0007
84 ULCERATIVE KERATITIS 2 0.0007
85 INFUSION SITE RASH 1 0.0007
86 MUCOSAL INFLAMMATION 19 0.0007
87 NAIL INFECTION 1 0.0007
88 ORAL PAIN 15 0.0007
89 INFUSION SITE EXTRAVASATION 4 0.0006
90 DRY EYE 32 0.0006
91 INTERSTITIAL LUNG DISEASE 31 0.0006
92 OXYGEN THERAPY 1 0.0006
93 TROPONIN I INCREASED 1 0.0006
94 GRANULOMA 2 0.0006
95 LYMPH NODE PAIN 1 0.0005
96 ORAL CANDIDIASIS 7 0.0005
97 CATHETER SITE INFECTION 2 0.0005
98 PERONEAL NERVE PALSY 3 0.0005
99 APHTHOUS ULCER 4 0.0005
100 ABNORMAL SENSATION IN EYE 2 0.0005
101 PRESCRIBED UNDERDOSE 9 0.0005
102 DISCOURAGEMENT 1 0.0004
103 VARICELLA 1 0.0004
104 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 1 0.0004
105 METASTASES TO PERITONEUM 1 0.0004
106 EXFOLIATIVE RASH 1 0.0004
107 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 1 0.0004
108 COMPRESSION FRACTURE 2 0.0004
109 LACRIMATION INCREASED 11 0.0004
110 ENTEROCOLITIS 2 0.0003
111 ATYPICAL PNEUMONIA 1 0.0003
112 OROPHARYNGEAL DISCOMFORT 3 0.0003
113 OSTEONECROSIS OF JAW 8 0.0003
114 INFUSION SITE SWELLING 2 0.0003
115 INFUSION SITE PRURITUS 1 0.0003
116 THERAPY CHANGE 3 0.0003
117 MENINGITIS 2 0.0003
118 LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV 1 0.0003
119 HYPERTRANSAMINASAEMIA 2 0.0003
120 JAUNDICE CHOLESTATIC 1 0.0003
121 METASTASIS 2 0.0003
122 FEELING DRUNK 2 0.0003
123 LEUKOENCEPHALOPATHY 1 0.0003
124 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
125 METASTASES TO LUNG 3 0.0003
126 NO ADVERSE EVENT 46 0.0003
127 CYSTITIS HAEMORRHAGIC 1 0.0002
128 INFUSION RELATED REACTION 16 0.0002
129 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
130 FACIAL PARALYSIS 2 0.0002
131 HORDEOLUM 1 0.0002
132 PRODUCT PRESCRIBING ISSUE 5 0.0002
133 TONGUE DISCOLOURATION 1 0.0002
134 SUSPECTED OFF LABEL USE 1 0.0002
135 PNEUMONIA BACTERIAL 2 0.0002
136 ROSACEA 1 0.0002
137 PERFORMANCE STATUS DECREASED 1 0.0002
138 PHOTOPHOBIA 4 0.0002
139 VEIN DISORDER 1 0.0002
140 PNEUMOCYSTIS JIROVECII PNEUMONIA 2 0.0002
141 VULVOVAGINAL PRURITUS 1 0.0002
142 EYE DISCHARGE 2 0.0002
143 DYSARTHRIA 7 0.0002
144 METASTASES TO BONE 3 0.0002
145 DENTAL CARIES 2 0.0002
146 VISUAL ACUITY REDUCED 6 0.0002
147 PRODUCT LEAKAGE 1 0.0002
148 SKIN TOXICITY 1 0.0002
149 MADAROSIS 2 0.0002
150 CYTOPENIA 2 0.0002
151 CONJUNCTIVITIS 3 0.0002
152 LEUKOPENIA 8 0.0002
153 MALIGNANT NEOPLASM PROGRESSION 16 0.0002
154 ACUTE RESPIRATORY FAILURE 3 0.0002
155 INFUSION SITE PAIN 2 0.0002
156 REFUSAL OF TREATMENT BY PATIENT 1 0.0002
157 CORONAVIRUS INFECTION 1 0.0002
158 EYE PRURITUS 5 0.0001
159 TASTE DISORDER 3 0.0001
160 AKATHISIA 2 0.0001
161 LUNG NEOPLASM MALIGNANT 6 0.0001
162 ENCEPHALITIS 1 0.0001
163 ORAL DISCOMFORT 2 0.0001
164 RIGHT VENTRICULAR FAILURE 1 0.0001
165 OFF LABEL USE 122 0.0001
166 FAECES SOFT 1 0.0001
167 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
168 PSYCHIATRIC SYMPTOM 1 0.0001
169 RASH MACULO-PAPULAR 3 0.0001
170 CATARACT 8 0.0001
171 TROPONIN INCREASED 1 0.0001
172 MUSCULOSKELETAL CHEST PAIN 2 0.0001
173 PELVIC FRACTURE 1 0.0001
174 NASAL DISCOMFORT 1 0.0001
175 EYE PAIN 7 0.0001
176 NEURALGIA 3 0.0001
177 INFUSION SITE ERYTHEMA 1 0.0001
178 CANDIDA INFECTION 2 0.0001
179 CIRCULATORY COLLAPSE 2 0.0001
180 ANURIA 1 0.0001
181 VISION BLURRED 15 0.0001
182 PRODUCT DISTRIBUTION ISSUE 1 0.0001
183 ERYTHEMA MULTIFORME 1 0.0001
184 HEPATIC FUNCTION ABNORMAL 4 0.0001
185 OCULAR HYPERAEMIA 5 0.0001
186 HAEMATOTOXICITY 1 0.0001
187 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 1 0.0001
188 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
189 PHARYNGEAL SWELLING 1 0.0001
190 VITREOUS FLOATERS 1 0.0001
191 HOSPICE CARE 1 0.0001
192 PERITONITIS BACTERIAL 1 0.0001
193 FEEDING DISORDER 2 0.0001
194 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 1 0.0001
195 ALOPECIA 19 0.0001
196 POOR VENOUS ACCESS 1 0.0001
197 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
198 BREAST PAIN 1 0.0001
199 BREAST CANCER METASTATIC 1 0.0001
200 WOUND INFECTION 1 0.0001
201 GLOSSODYNIA 2 0.0001
202 INTESTINAL PERFORATION 1 0.0001
203 OCULAR DISCOMFORT 1 0.0001
204 EYE IRRITATION 5 0.0001
205 BACTERAEMIA 1 0.0001
206 CEREBRAL HAEMORRHAGE 3 0.0001
207 ENCEPHALOPATHY 2 0.0001
208 THROMBOCYTOPENIA 9 0.0001
209 AGEUSIA 2 0.0001
210 PNEUMONIA ASPIRATION 2 0.0001
211 INTRAOCULAR PRESSURE INCREASED 1 0.0001
212 FEBRILE NEUTROPENIA 5 0.0001
213 COUGH 21 0.0001
214 PAIN OF SKIN 2 0.0001
215 BLOOD BILIRUBIN INCREASED 2 0.0001
216 THROAT TIGHTNESS 2 0.0001
217 RASH PRURITIC 4 0.0001
218 NEUTROPENIA 10 0.0001
219 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
220 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
221 SEASONAL ALLERGY 1 0.0001
222 SINUS TACHYCARDIA 1 0.0001
223 PARAESTHESIA ORAL 1 0.0001
224 MYELODYSPLASTIC SYNDROME 1 0.0001
225 WEIGHT DECREASED 19 0.0001
226 ASCITES 2 0.0001
227 ACUTE MYOCARDIAL INFARCTION 2 0.0001
228 EPILEPSY 2 0.0001
229 INSURANCE ISSUE 1 0.0001
230 NEUROPATHY PERIPHERAL 6 0.0001
231 SEPSIS 7 0.0001
232 RHINORRHOEA 4 0.0001
233 EYE DISORDER 2 0.0001
234 DEATH 51 0.0001
235 INFLAMMATION 3 0.0001
236 NEOPLASM PROGRESSION 2 0.0001
237 HYPOXIA 2 0.0001
238 LEUKOCYTOSIS 1 0.0001
239 OSTEOMYELITIS 1 0.0001
240 RASH 24 0.0001
241 HYPERGLYCAEMIA 2 0.0001
242 RESPIRATORY FAILURE 4 0.0001
243 UNDERDOSE 4 0.0001
244 HYPOCALCAEMIA 1 0.0001
245 FRACTURE 1 0.0001
246 PULMONARY FIBROSIS 1 0.0001
247 POST PROCEDURAL COMPLICATION 1 0.0001
248 DISABILITY 1 0.0001
249 NAUSEA 40 0.0001
250 CYTOKINE RELEASE SYNDROME 1 0.0000
251 PLEURAL EFFUSION 3 0.0000
252 DRY MOUTH 4 0.0000
253 DYSKINESIA 2 0.0000
254 BLINDNESS 2 0.0000
255 NEUTROPHIL COUNT DECREASED 2 0.0000
256 PRODUCT DOSE OMISSION ISSUE 14 0.0000
257 MOUTH ULCERATION 1 0.0000
258 EATING DISORDER 1 0.0000
259 URINARY TRACT INFECTION 8 0.0000
260 SEPTIC SHOCK 2 0.0000
261 DYSPNOEA 26 0.0000
262 MELAENA 1 0.0000
263 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
264 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
265 THROAT IRRITATION 2 0.0000
266 HEPATIC ENZYME INCREASED 3 0.0000
267 PRODUCT AVAILABILITY ISSUE 1 0.0000
268 SKIN IRRITATION 2 0.0000
269 OROPHARYNGEAL PAIN 4 0.0000
270 FATIGUE 33 0.0000
271 DIABETIC KETOACIDOSIS 1 0.0000
272 MALAISE 18 0.0000
273 LUNG DISORDER 2 0.0000
274 PNEUMONIA 13 0.0000
275 ABDOMINAL PAIN LOWER 1 0.0000
276 CHEST DISCOMFORT 4 0.0000
277 THERAPY CESSATION 2 0.0000
278 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
279 ANAPHYLACTIC SHOCK 1 0.0000
280 DECREASED APPETITE 9 0.0000
281 NERVOUSNESS 2 0.0000
282 DEAFNESS 1 0.0000
283 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
284 DEHYDRATION 5 0.0000
285 DRY SKIN 5 0.0000
286 ANAEMIA 7 0.0000
287 CONSTIPATION 8 0.0000
288 RESPIRATORY DISTRESS 1 0.0000
289 ANAPHYLACTIC REACTION 2 0.0000
290 PANCYTOPENIA 2 0.0000
291 BLISTER 2 0.0000
292 HYPONATRAEMIA 2 0.0000
293 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
294 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
295 PYREXIA 12 0.0000
296 SEIZURE 4 0.0000
297 LIVER FUNCTION TEST ABNORMAL 1 0.0000
298 SURGERY 2 0.0000
299 RESPIRATORY DISORDER 1 0.0000
300 HEPATIC FAILURE 1 0.0000
301 CORONARY ARTERY DISEASE 1 0.0000
302 ILL-DEFINED DISORDER 2 0.0000
303 EMOTIONAL DISORDER 1 0.0000
304 VISUAL IMPAIRMENT 4 0.0000
305 SWOLLEN TONGUE 1 0.0000
306 DRUG-INDUCED LIVER INJURY 1 0.0000
307 DYSPHAGIA 3 0.0000
308 PULMONARY EMBOLISM 3 0.0000
309 DRUG INTOLERANCE 3 0.0000
310 LACTIC ACIDOSIS 1 0.0000
311 LIP SWELLING 1 0.0000
312 SKIN DISORDER 1 0.0000
313 GAIT INABILITY 1 0.0000
314 ILLNESS 3 0.0000
315 HEART RATE DECREASED 1 0.0000
316 SKIN BURNING SENSATION 2 0.0000
317 MYELOSUPPRESSION 1 0.0000
318 DYSGEUSIA 2 0.0000
319 EYE SWELLING 1 0.0000
320 WEIGHT INCREASED 6 0.0000
321 COLITIS 1 0.0000
322 CARDIAC FAILURE 2 0.0000
323 SKIN EXFOLIATION 2 0.0000
324 HYPOACUSIS 1 0.0000
325 BALANCE DISORDER 2 0.0000
326 MENTAL DISORDER 1 0.0000
327 RENAL FAILURE 3 0.0000
328 TACHYCARDIA 2 0.0000
329 GASTROINTESTINAL DISORDER 2 0.0000
330 ADVERSE DRUG REACTION 2 0.0000
331 THERAPY NON-RESPONDER 1 0.0000
332 ADVERSE EVENT 2 0.0000
333 HYPOKALAEMIA 1 0.0000
334 RENAL DISORDER 1 0.0000
335 SWELLING 2 0.0000
336 PRODUCTIVE COUGH 1 0.0000
337 RASH ERYTHEMATOUS 1 0.0000
338 HYPOAESTHESIA 3 0.0000
339 FLUID RETENTION 1 0.0000
340 ERYTHEMA 4 0.0000
341 MUSCULOSKELETAL PAIN 1 0.0000
342 SPEECH DISORDER 1 0.0000
343 PLATELET COUNT DECREASED 2 0.0000
344 ASTHENIA 7 0.0000
345 TREATMENT NONCOMPLIANCE 1 0.0000
346 PRURITUS 7 0.0000
347 NECK PAIN 1 0.0000
348 TOXICITY TO VARIOUS AGENTS 3 0.0000
349 HERPES ZOSTER 1 0.0000
350 DYSPHONIA 1 0.0000
351 BONE PAIN 1 0.0000
352 CHILLS 2 0.0000
353 WHEEZING 1 0.0000
354 OEDEMA PERIPHERAL 2 0.0000
355 FEELING HOT 1 0.0000
356 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
357 AMNESIA 1 0.0000
358 SWELLING FACE 1 0.0000
359 HYPOTENSION 3 0.0000
360 SOMNOLENCE 3 0.0000
361 VOMITING 7 0.0000
362 INJECTION SITE REACTION 1 0.0000
363 HOSPITALISATION 2 0.0000
364 BACK PAIN 3 0.0000
365 ABDOMINAL PAIN 3 0.0000
366 CARDIAC FAILURE CONGESTIVE 1 0.0000
367 THROMBOSIS 1 0.0000
368 DIARRHOEA 8 0.0000
369 INFLUENZA LIKE ILLNESS 1 0.0000
370 CARDIAC ARREST 1 0.0000
371 TREATMENT FAILURE 1 0.0000
372 COMPLETED SUICIDE 1 0.0000
373 RENAL IMPAIRMENT 1 0.0000
374 CEREBROVASCULAR ACCIDENT 2 0.0000
375 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
376 NASOPHARYNGITIS 2 0.0000
377 CHEST PAIN 2 0.0000
378 PRODUCT USE ISSUE 2 0.0000
379 MIGRAINE 1 0.0000
380 DYSPEPSIA 1 0.0000
381 ABDOMINAL DISTENSION 1 0.0000
382 HAEMORRHAGE 1 0.0000
383 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
384 MUSCULAR WEAKNESS 1 0.0000
385 INCORRECT DOSE ADMINISTERED 2 0.0000
386 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
387 PALPITATIONS 1 0.0000
388 FEELING ABNORMAL 2 0.0000
389 DRUG INEFFECTIVE 11 0.0000
390 INJECTION SITE ERYTHEMA 1 0.0000
391 INFECTION 1 0.0000
392 PAIN IN EXTREMITY 2 0.0000
393 ACUTE KIDNEY INJURY 1 0.0000
394 CONFUSIONAL STATE 1 0.0000
395 MYALGIA 1 0.0000
396 MYOCARDIAL INFARCTION 1 0.0000
397 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
398 HYPERSENSITIVITY 1 0.0000
399 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
400 ABDOMINAL PAIN UPPER 1 0.0000
401 DEPRESSION 1 0.0000
402 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
403 DIZZINESS 2 0.0000
404 INSOMNIA 1 0.0000
405 CONDITION AGGRAVATED 1 0.0000
406 HEADACHE 2 0.0000
407 FALL 1 0.0000
408 PAIN 1 0.0000